PD166326

Code: PZ0366-25MG D2-231

Biochem/physiol Actions

ATP-competitive dual BCR-ABL and Src kinase inhibitor

PD166326 is an ATP-competitive dual BCR-ABL and Src kinase inhibitor. In some studies it h...


read more

Your Price
€512.50 25MG
€630.38 inc. VAT
REQUEST

Biochem/physiol Actions

ATP-competitive dual BCR-ABL and Src kinase inhibitor

PD166326 is an ATP-competitive dual BCR-ABL and Src kinase inhibitor. In some studies it has been found to be more potent than imatinib with inhibition of cancer growth in the low nanomolar range or even picomolar range in various biological systems.

Legal Information

Pfizer is a registered trademark of Pfizer, Inc.

assay≥98% (HPLC)
colorwhite to light brown
formpowder
manufacturer/tradenamePfizer®
originatorPfizer
Quality Level100
SMILES stringO=C1N(C)C2=C(C=NC(NC3=CC=CC(CO)=C3)=N2)C=C1C4=C(Cl)C=CC=C4Cl
solubilityDMSO: 2 mg/mL, clear
storage temp.room temp
Cas Number185039-91-2
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.